Zdrowie i gospodarka · 14/03/2002

FDA Seeks Public Comment on Proposed Regulations for In Vivo Radiopharmaceuticals

The Food and Drug Administration (FDA) is seeking public comment on proposed regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring. The agency must publish this notice under the Paperwork Reduction Act of 1995 and allow 60 days for public response.